The arrival of weight-loss drugs like Ozempic rattled ResMed shareholders but so far the fear has been misplaced, writes Jun Bei Liu.
Jun Bei Liu
 | Jun Bei Liu is the founder of Ten Cap, and lead portfolio manager of its flagship fund, the Ten Cap Alpha Plus fund. She is also a popular media personality and a highly sought after public speaker about her investment views. She has been appointed a Core Fund Manager for Hearts and Minds Investments and volunteers for the Raise Foundation Board. Jun Bei is fluent in Mandarin and English after emigrating to Australia from China at 16. She completed a commerce degree at the University of New South Wales, followed by a number of finance credentials including GAICD and CFA. |
18 results for Jun Bei Liu:
Headquartered in Auckland, Fisher & Paykel Healthcare has translated its robust sales growth into even stronger earnings growth.
Zip Co Limited is the second-largest buy now, pay later provider in Australia. Here's why it should be in your portfolio.
Pro Medicus is uniquely placed to become a platform for the use of AI in medical imaging, so is it a buy, hold or sell?
Treasury Wine Estates owns and produces the great Australian wine, Penfolds, so should you buy, hold or sell TWE shares?
The share price of Cettire, the online marketplace for luxury fashion, has gone up more than 10-fold as young Aussies seek out designer goods.
Altium has been a driving force since its founding, with approximately 40% market share in the small medium business segment. So are Altium shares a buy, hold or sell?
Temple & Webster might be your go-to when you're shopping for your home, but what about your share portfolio?
Family tracking app Life360 (ASX:360) has notched substantial user growth since launch, but is it a compelling investment?
Constructing warehousing infrastructure for giants like Amazon means Goodman Group isn't your typical real estate player.
